{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:08:00Z","timestamp":1759334880531,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jaad.2013.04.017","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T12:30:14Z","timestamp":1368275414000},"page":"221-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intravenous immune globulin therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis"],"prefix":"10.1016","volume":"69","author":[{"given":"Marnie R.","family":"Ririe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Blaylock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Y.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.04.017_bib1","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1537-2995.2003.00519.x","article-title":"Intravenous immune globulins: an update for clinicians","volume":"43","author":"Knezevic-Maramica","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.jaad.2013.04.017_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jaad.2011.12.014","article-title":"Toxic epidermal necrolysis: five years of treatment experience from a burn unit","volume":"67","author":"Firoz","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.04.017_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.139.1.26","article-title":"Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases","volume":"139","author":"Prins","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.04.017_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.burns.2006.08.014","article-title":"Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach: a retrospective analysis","volume":"33","author":"Stella","year":"2007","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2013.04.017_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2230.2005.01863.x","article-title":"The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"30","author":"Yeung","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.04.017_bib6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1537-2995.2006.00792.x","article-title":"Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature","volume":"46","author":"Darabi","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.jaad.2013.04.017_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.transci.2011.11.004","article-title":"Hemolysis upon intravenous immunoglobulin transfusion","volume":"46","author":"Padmore","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jaad.2013.04.017_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.ajkd.2009.06.013","article-title":"Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion","volume":"55","author":"Welles","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaad.2013.04.017_bib9","first-page":"1","article-title":"Intravenous immune globulin (IVIG): hemolytic reactions","volume":"19","author":"Taylor","year":"2009","journal-title":"Can Adverse React Newsletter"},{"key":"10.1016\/j.jaad.2013.04.017_bib10","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2215\/CJN.04540709","article-title":"Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients","volume":"4","author":"Kahwaji","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2013.04.017_bib11","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1537-2995.2008.01721.x","article-title":"Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis","volume":"48","author":"Daw","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.jaad.2013.04.017_bib12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ajh.21544","article-title":"A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin","volume":"84","author":"Gordon","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2013.04.017_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1546-0096-10-10","article-title":"Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases","volume":"10","author":"Berard","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jaad.2013.04.017_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biologicals.2004.10.004","article-title":"Potential approaches to prevent uncommon hemolytic side effects of AB0 antibodies in plasma derivatives","volume":"33","author":"Buchta","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.jaad.2013.04.017_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-3148.2011.01078.x","article-title":"Hemolysis after treatment with intravenous immunoglobulin due to anti-A","volume":"21","author":"Morgan","year":"2011","journal-title":"Transfus Med"},{"key":"10.1016\/j.jaad.2013.04.017_bib16","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/cc11480","article-title":"Mannitol increases renal blood flow and maintains filtration fraction and oxygenation in postoperative acute kidney injury: a prospective interventional study","volume":"16","author":"Bragadottir","year":"2012","journal-title":"Crit Care"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213004039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213004039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:28:50Z","timestamp":1759271330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213004039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0190962213004039"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.04.017","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous immune globulin therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}